Tag Archives: RRMM medicine
Teclistamab Shows High Response Rate and Good Tolerability Profile in Patients with Multiple Myeloma
According to outcomes from an ongoing study presented during the II’nd European Myeloma Network Meeting, Teclistamab shows high response rate […]
